Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: J Hypertens. 2016 Oct;34(10):2008–2025. doi: 10.1097/HJH.0000000000001029

FIGURE 3.

FIGURE 3

Plasma angiotensin II levels (a), plasma renin activity (b), plasma angiotensin-converting enzyme activity (c), and the ratio of plasma angiotensin II to angiotensin I levels (d) in indole-3-carbinol induced and noninduced Cyp1a1-Ren-2 transgenic rats. Effects of epoxyeicosatrienoic acid analog and angiotensin-converting enzyme inhibition treatment are also shown. *P < 0.05 versus untreated noninduced rats #P < 0.05 versus *marked values. @P < 0.05 versus untreated indole-3-carbinol induced rats.